(Q34583882)

3 August 2017

1 reference

title

Therapeutic exploitation of the p53 pathway (English)

1 reference

3 August 2017

David P Lane

1

1 reference

3 August 2017

Sonia Lain

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2002

1 reference

Trends in Molecular Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

4 Suppl

1 reference

3 August 2017

page(s)

S38-42

1 reference

Strategies for manipulating the p53 pathway in the treatment of human cancer.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

New approaches to understanding p53 gene tumor mutation spectra

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Tumor-specific mutations in p53: the acid test

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

The p53-deficient mouse: a model for basic and applied cancer studies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

p53 mutant mice that display early ageing-associated phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Targeting gene expression to tumor cells with loss of wild-type p53 function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Reactivation of mutant p53: a new strategy for cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Pharmacological rescue of mutant p53 conformation and function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Functions of the MDM2 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Checkpoints: How to activate p53

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

The INK4a/ARF network in tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Activation of p53 by roscovitine-mediated suppression of MDM2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Activation of p53 in cervical carcinoma cells by small molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

Nucleolar Arf sequesters Mdm2 and activates p53

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902309-2

7 January 2021

10.1016/S1471-4914(02)02309-2

Identifiers

DOI

1 reference

3 August 2017

1 reference